Thomas Begley

Thomas Begley is a Co-Founder and Scientific Advisor at Codomax since January 2023 and Co-Founder of HOVANA, where innovative genomic medicines are developed to address translational dysfunction in serious diseases. As a long-term faculty member at the University at Albany, SUNY, Thomas Begley has held various roles including Director of the Training Program in RNA Science and Technology, Professor of Biological Sciences, and Associate Director of the RNA Institute since 2004. Thomas Begley's earlier academic positions include Assistant Professor and Associate Professor at SUNY Albany, a Postdoctoral Fellow at MIT, and a Postdoctoral Associate at Harvard T.H. Chan School of Public Health. Educational achievements consist of a degree in Biological Engineering from MIT and earlier studies at the University at Albany.